Triple
T33388450
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | pomalidomide |
E854983
|
entity |
| Predicate | instanceOf |
P0
|
FINISHED |
| Object | thalidomide analogue |
C27668
|
CONCEPT FINISHED |
How this triple was built (1 step)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
CD
Concept disambiguation
gpt-5-mini-2025-08-07
Target class: thalidomide analogue Context triple: [pomalidomide, instanceOf, thalidomide analogue]
-
A.
semisynthetic derivative of artemisinin
A semisynthetic derivative of artemisinin is a chemically modified compound produced from naturally sourced artemisinin to improve its pharmacological properties, such as stability, bioavailability, or antimalarial efficacy.
-
B.
angiopoietin-2 inhibitor
An angiopoietin-2 inhibitor is a therapeutic agent that selectively blocks the activity of angiopoietin-2 to stabilize blood vessels, reduce pathological angiogenesis, and modulate vascular inflammation in diseases such as cancer and ocular disorders.
-
C.
dibenzazepine derivative
A dibenzazepine derivative is a chemical compound structurally based on the dibenzazepine tricyclic scaffold, in which one or more substituents on the core ring system have been modified.
-
D.
Janus kinase inhibitor
A Janus kinase inhibitor is a drug that selectively blocks Janus kinase (JAK) enzymes to modulate cytokine signaling and reduce inflammation or abnormal immune activity in various diseases.
-
E.
antineoplastic immunomodulating agent
chosen
An antineoplastic immunomodulating agent is a drug that treats cancer by modifying or enhancing the body’s immune response to recognize and destroy malignant cells.
- F. None of above.
Provenance (1 batch)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69f3496d54048190a1cb91fdd7caa6ea |
completed | April 30, 2026, 12:22 p.m. |
Created at: May 1, 2026, 1:35 a.m.